Emcure Pharma Shares In Green After Jefferies Bestows Shark Tank Judge Nampita Thapar-Led Company With A 'Buy' Rating

Emcure Pharma Shares In Green After Jefferies Bestows Shark Tank Judge Nampita Thapar-Led Company With A 'Buy' Rating

This positive rating from the New York-based group has provided an impetus for Emcure's performance at Dalal Street. The company shares made gains on Monday, August 26.

G R MukeshUpdated: Tuesday, August 27, 2024, 11:27 AM IST
article-image

Namita Thapar's Emcure Pharmaceuticals Ltd. was listed only a month and a half ago, on July 10, 2024. The Maharashtra-based pharma got some positive news as it bagged its first 'Buy' rating from a renowned American rating agency, Jefferies.

Jefferies Gives Emcure Buy Call

This positive rating from the New York-based group has provided an impetus for Emcure's performance at Dalal Street. The company shares made gains on Monday, August 26.

The broking firm has assigned a price target of Rs 1,600. Currently, the share is priced above Rs 1,400.

Over the past 5 trading sessions alone, the company has gained 6.31 per cent.

On August 26, the company shares jumped significantly, after which, it took a downward trajectory. The fortunes of the company's shares have wavered a little, at the half-way mark.

Emcure Shares Boom

After reaching the high of Rs 1,440.80, the shares slumped, yet continued to be in green. Thereafter, there was a recovery that was observed. At 12:33 IST, Emcure shares gained by 1.44 per cent or Rs 20.00, taking the overall value of the share to Rs 1,405.20.  

According to reports, the company accrued a total revenue of Rs 1,815.14 crore in the previous quarter. Furthermore, the company also added an operating income of Rs 242.73 crore. The company's operating expenses stood at Rs 1,572.41 crore. In all, it saw a net income of Rs 144.08 crore.

Namita Thapar, who is seen as the face of the company, was famously a judge in the Indian version of the TV reality franchise show, Shark Tank India.

Namita Thapar, who is seen as the face of the company, was famously a judge in the Indian version of the TV reality franchise show, Shark Tank India. | Instagram - Namita Thapar

A 'Buy' call is deemed a positive development and is issued at a time, when it is anticipated that the stock in focus is expected to grow and expand in the time to come. In the case of Emcure, Jefferies' bullishness comes after the stock has soared by about 40 per cent from its issue price of Rs 1,008.

Namita Thapar, who is seen as the face of the company was famously a judge in the Indian version of the TV reality franchise show Shark Tank India.

RECENT STORIES

Cognizant Reports "Better-Than-Expected" Growth With Net Income Rising 14% To USD 645 Million For...

Cognizant Reports

The 25% US Tariffs & Penalty For Russian Imports Could Dent India's GDP Growth By 30 Basis Points

The 25% US Tariffs & Penalty For Russian Imports Could Dent India's GDP Growth By 30 Basis Points

I Am Deeply Grateful, Says Microsoft CEO Satya Nadella While Addressing 15,000 Employees Who Lost...

I Am Deeply Grateful, Says Microsoft CEO Satya Nadella While Addressing 15,000 Employees Who Lost...

Shipments Worth Over $25 Billion, Covering Pharmaceuticals & Smartphones Secure From Steeper Duties

Shipments Worth Over $25 Billion, Covering Pharmaceuticals & Smartphones Secure From Steeper Duties

India’s FY26 GDP Growth Likely At 6.5% As Experts Cite Rate Cuts, Tax Relief, And Urban Demand...

India’s FY26 GDP Growth Likely At 6.5% As Experts Cite Rate Cuts, Tax Relief, And Urban Demand...